The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Psychopharmacology: The third generation of progress
O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Norepinephrine in Depressive Reactions: A Review
BUNNEY, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,153
Neurotransmitter functions of mammalian tachykinins.
Otsuka, M., & Yoshioka, K. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.2.229 · Cited by 1,080
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 713
Neuropeptides in perspective: The last ten years
Hökfelt, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90333-u · Cited by 618
Montejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 1×
“This is clinically significant as sexual dysfunction is a major problem associated with the use of many commonly prescribed antidepressants (Montejo-Gonzalez et al, 1997).”
BackgroundMammalian Tachykinin Receptors
Nakanishi, S. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.001011 · Cited by 497
The mammalian tachykinin receptors
Maggi, C. A. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(94)00292-u · Cited by 486
Molecular characterization of a functional cDNA for rat substance P receptor
Yokota, Y., Sasai, Y., Tanaka, K., Fujiwara, T., Tsuchida, K., Shigemoto, R., Kakizuka, A., Ohkubo, H., & Nakanishi, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84619-7 · Cited by 456
Zur Serotonin-Hypothese der Depression*
Lesch, K., & Beckmann, H. (1990) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1001206 · Cited by 391
Molecular Characterization of a Functional cDNA Encoding the Rat Substance P Receptor
Hershey, A. D., & Krause, J. E. (1990) · Science · doi:10.1126/science.2154852 · Cited by 345
Santarelli, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041596398 · Cited by 303
Dopamine and depression: A review of recent evidence. I. Empirical studies
Willner, P. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90005-x · Cited by 273
Current Developments in Psychopharmacology
Sullivan, J. L. (1978) · Psychosomatics · doi:10.1016/s0033-3182(78)71012-1 · Cited by 264
Trindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 252
Gerard, N. P., Garraway, L. A., Eddy, R. L., Shows, T. B., Iijima, H., Paquet, J. L., & Gerard, C. (1991) · Biochemistry · doi:10.1021/bi00108a006 · Cited by 177
Arora, R. C., & Meltzer, H. Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90384-6 · Cited by 175
Froger, N., Gardier, A. M., Moratalla, R., Alberti, I., Léna, I., Boni, C., Felipe, C. D., Rupniak, N. M. J., Hunt, S. P., Jacquot, C., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08188.2001 · Cited by 140
Shaikh, M. B., Steinberg, A., & Siegel, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91070-9 · Cited by 136
Deakin, J. F. W., Pennell, I., Upadhyaya, A. J., & Lofthouse, R. (1990) · Psychopharmacology · doi:10.1007/bf02253723 · Cited by 132 · cited 1×
“Subsequent literature (eg Arora and Meltzer, 1989; Deakin et al, 1990; Delgado et al, 1989; Maes et al, 1990; Meltzer and Lowy, 1987; M ller et al, 1990; Sarrias et al, 1987; Upadhyaya et al, 1991; Young et al, 1985) suggested that serotonergic mechanisms may in part underlie vulnerability to major…”
BackgroundNeuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects
Delgado, P. L., Charney, D. S., Price, L. H., LANDIS, H. D., & Heninger, G. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90114-8 · Cited by 124
Synaptic Effects of Antidepressants
RICHELSON, E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00001 · Cited by 120 · cited 1×
“Despite innovative hypotheses that attempt to unify current knowledge, (Duman et al, 1997; Owens, 1996–1997; Richelson, 1996; Risch, 1997), a clear explanation of the pathophysiology of depression remains elusive.”
BackgroundShirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., & Takahashi, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00812-8 · Cited by 113
(1935) · The Lancet · doi:10.1016/s0140-6736(00)57102-5 · Cited by 111
The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret
Tattersall, F. D., Rycroft, W., Hargreaves, R. J., et al. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90649-3 · Cited by 108
Tattersall, F. D., Rycroft, W., Hill, R. G., et al. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90018-3 · Cited by 92
Central tachykinins: mediators of defence reaction and stress reactions
Čulman, J., & Unger, T. A. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-122 · Cited by 92
Hahn, M. K., & Bannon, M. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00319-x · Cited by 90
Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization.
Unger, T., Carolus, S. M., Demmert, G., et al. (1988) · Circulation Research · doi:10.1161/01.res.63.4.812 · Cited by 90
Decreased plasma serotonin in melancholic patients: A study with clomipramine
Sarrias, M. J., Artigas, F., Martı́nez, E., Gelpı́, E., Álvarez, E., Udina, C., & Casas, M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90100-4 · Cited by 88
Melancholic/endogenous depression and response to somatic treatment and placebo
Peselow, E. D., Sanfilipo, M. P., Difiglia, C., & Fieve, R. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1324 · Cited by 82
Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity
Conley, R. K., Cumberbatch, M. J., Mason, G. S., Williamson, D. J., Harrison, T., Locker, K. L., Swain, C. J., Maubach, K. A., O’Donnell, R., Rigby, M., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07730.2002 · Cited by 81
Cheeta, S., Tucci, S. A., Sandhu, J., Williams, A. R., Rupniak, N. M. J., & File, S. E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02846-3 · Cited by 78
Smith, D. W., Hewson, L., Fuller, P. J., Williams, A. R., Wheeldon, A., & Rupniak, N. M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01976-9 · Cited by 73
Boyce, S., Smith, D., Carlson, E. J., Hewson, L., Rigby, M., O’Donnell, R., Harrison, T., & Rupniak, N. M. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00051-x · Cited by 72
Maubach, K. A., Martin, K., Chicchi, G. G., Harrison, T., Wheeldon, A., Swain, C. J., Cumberbatch, M. J., Rupniak, N. M. J., & Seabrook, G. R. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00467-5 · Cited by 72
Maes, M. H. J., Jacobs, M. ‐., Suy, E., Minner, B., Leclercq, C., Christiaens, F., & Raus, J. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb06443.x · Cited by 67
Molecular and cellular mechanisms of antidepressant drugs
Owens, M. J. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:4<153::aid-da1>3.0.co;2-g · Cited by 67
Neurokinin receptor subtypes characterized by biological assays
Regoli, D. C., Nguyen, Q. T., & Jukic, D. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00712-8 · Cited by 65
Paroxetine in the treatment of melancholia and severe depression
Tignol, J., Stoker, M. J., & Dunbar, G. C. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199211000-00005 · Cited by 61
Elliott, P. J., Nemeroff, C. B., & Kilts, C. D. (1986) · Brain Research · doi:10.1016/0006-8993(86)91087-5 · Cited by 52
Brodin, E., Ögren, S., & Theodorsson-Norheim, E. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90151-1 · Cited by 44
Heiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90077-9 · Cited by 43
Upadhyaya, A. K., Pennell, I., Cowen, P. J., & Deakin, J. F. W. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90042-q · Cited by 40
Alcohol consumption and lifestyle in medical students
File, S. E., Mabbutt, P. S., & Shaffer, J. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800104 · Cited by 40
Isolation and characterisation of the human lung NK-1 receptor cDNA
Hopkins, B., Powell, S. J., Danks, P., Briggs, I., & Graham, A. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81181-7 · Cited by 39
Barden, N., Daigle, M., Picard, V., & Paolo, T. D. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb04816.x · Cited by 38
Sadowski, S. J., Huang, R. R., Fong, T. M., Marko, O., & Cascieri, M. A. (1993) · Neuropeptides · doi:10.1016/0143-4179(93)90001-q · Cited by 31
Recent advances in depression research: from stress to molecular biology and brain imaging.
Risch, S. C. (1997) · PubMed · Cited by 25
Lemoine, P., Boulenger, J.-P., Caillard, V., Tanne, N., & BONNET, D. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014464 · Cited by 7
Cited by
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Neuropeptide substance P and the immune response
Mashaghi, A., Marmalidou, A., Tehrani, M., Grace, P. M., Pothoulakis, C., & Dana, R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2293-z · Cited by 493
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
Holmes, A., Heilig, M., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 403
The role of substance P in stress and anxiety responses
Ebner, K., & Singewald, N. (2006) · Amino Acids · doi:10.1007/s00726-006-0335-9 · Cited by 306
Metadata
- Authors
- Kramer, M. S., Winokur, A., Kelsey, J., Preskorn, S. H., Rothschild, A. J., Snavely, D., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D., Apter, J. T., Cunningham, L., Kling, M., Bari, M., Getson, A., & Lee, Y.
- Venue
- Neuropsychopharmacology
- Published
- 2003-12-03
- Volume
- 29
- Issue
- 2
- Pages
- 385-392
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2045030807
- Cited by
- 256
- References
- 54
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.